Evolva Financial Statements From 2010 to 2024

EVE Stock  CHF 0.85  0.01  1.16%   
Evolva Holding financial statements provide useful quarterly and yearly information to potential Evolva Holding SA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Evolva Holding financial statements helps investors assess Evolva Holding's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Evolva Holding's valuation are summarized below:
Evolva Holding SA does not presently have any fundamental signals for analysis.
Check Evolva Holding financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolva Holding's main balance sheet or income statement drivers, such as , as well as many indicators such as . Evolva financial statements analysis is a perfect complement when working with Evolva Holding Valuation or Volatility modules.
  
This module can also supplement various Evolva Holding Technical models . Check out the analysis of Evolva Holding Correlation against competitors.

Evolva Holding SA Company Current Valuation Analysis

Evolva Holding's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Evolva Holding Current Valuation

    
  91.22 M  
Most of Evolva Holding's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Evolva Holding SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Evolva Holding SA has a Current Valuation of 91.22 M. This is 99.36% lower than that of the Healthcare sector and 98.04% lower than that of the Biotechnology industry. The current valuation for all Switzerland stocks is 99.45% higher than that of the company.

Evolva Holding SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Evolva Holding's current stock value. Our valuation model uses many indicators to compare Evolva Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evolva Holding competition to find correlations between indicators driving Evolva Holding's intrinsic value. More Info.
Evolva Holding SA is one of the top stocks in return on equity category among its peers. It is rated # 2 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evolva Holding's earnings, one of the primary drivers of an investment's value.

About Evolva Holding Financial Statements

Evolva Holding investors use historical fundamental indicators, such as Evolva Holding's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Evolva Holding. Please read more on our technical analysis and fundamental analysis pages.
Evolva Holding SA discovers, develops, and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, United States, Denmark, and internationally. The company was founded in 2004 and is headquartered in Reinach, Switzerland. EVOLVA N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 67 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Evolva Stock Analysis

When running Evolva Holding's price analysis, check to measure Evolva Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolva Holding is operating at the current time. Most of Evolva Holding's value examination focuses on studying past and present price action to predict the probability of Evolva Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolva Holding's price. Additionally, you may evaluate how the addition of Evolva Holding to your portfolios can decrease your overall portfolio volatility.